Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1b
Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1b
The primary objective of the study is to evaluate the adherence to the treatment with
 interferon beta-1b, in patients diagnosed with isolated syndrome (CIS), relapsing-remitting
 multiple sclerosis (RRMS), or secondary progressive multiple sclerosis (SPMS) who had more
 than 6 months in treatment.
Inclusion Criteria:

 -  Patients with relapsing-remitting MS (RRMS), secondary progressive MS (SPMS) or
 patients with a first outbreak or clinically isolated syndrome (CIS) that carry more
 than 6 months in treatment with interferon beta-1b

 Exclusion Criteria:

 -